We demonstrated previously that the Th17 subset of CD4+ T cells played a central role in the pathogenesis of GPI-induced arthritis; GPI-specific CD4+ T cells were skewed to TH-17 at the time of onset, and blockade of IL-17 resulted in a significant amelioration of arthritis [7]. Here, IL17A is linked to arthritic joint disease.